A real-life comparison of pulmonary and nasal outcomes in patients with severe asthma and nasal polyposis treated with T2-biologics

BACKGROUND: Severe asthma (SA) with comorbid chronic rhinosinusitis with nasal polyps (CRSwNP) is frequently associated with type 2 (T2) inflammatory endotype. Consequently, therapeutic targets are T2 biologics. The present retrospective study aimed to analyze and compare the clinical efficacy of me...

Descripción completa

Detalles Bibliográficos
Autores principales: Förster-Ruhrmann, Ulrike, Stergioudi, Dafni, Szczepek, Agnieszka J., Fluhr, Joachim W., Zuberbier, Torsten, Olze, Heidi, Bergmann, Karl-Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2023
Materias:
Full-Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958493/
https://www.ncbi.nlm.nih.gov/pubmed/36852411
http://dx.doi.org/10.1016/j.waojou.2023.100746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958493/
https://www.ncbi.nlm.nih.gov/pubmed/36852411
http://dx.doi.org/10.1016/j.waojou.2023.100746

Ejemplares similares